These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 29432603)
1. In Vitro Screening for Seizure Liability Using Microelectrode Array Technology. Bradley JA; Luithardt HH; Metea MR; Strock CJ Toxicol Sci; 2018 May; 163(1):240-253. PubMed ID: 29432603 [TBL] [Abstract][Full Text] [Related]
2. Screening for Neurotoxicity with Microelectrode Array. Bradley JA; Strock CJ Curr Protoc Toxicol; 2019 Feb; 79(1):e67. PubMed ID: 30575314 [TBL] [Abstract][Full Text] [Related]
3. Assessing seizure liability using multi-electrode arrays (MEA). Fan J; Thalody G; Kwagh J; Burnett E; Shi H; Lewen G; Chen SJ; Levesque P Toxicol In Vitro; 2019 Mar; 55():93-100. PubMed ID: 30528373 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set. McConnell ER; McClain MA; Ross J; Lefew WR; Shafer TJ Neurotoxicology; 2012 Oct; 33(5):1048-57. PubMed ID: 22652317 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability. Easter A; Sharp TH; Valentin JP; Pollard CE J Pharmacol Toxicol Methods; 2007; 56(2):223-33. PubMed ID: 17600733 [TBL] [Abstract][Full Text] [Related]
6. Comparative study for the IMI2-NeuroDeRisk project on microelectrode arrays to derisk drug-induced seizure liability. Zhai J; Traebert M; Zimmermann K; Delaunois A; Royer L; Salvagiotto G; Carlson C; Lagrutta A J Pharmacol Toxicol Methods; 2023; 123():107297. PubMed ID: 37499956 [TBL] [Abstract][Full Text] [Related]
7. Do in vitro assays in rat primary neurons predict drug-induced seizure liability in humans? Kreir M; Van Deuren B; Versweyveld S; De Bondt A; Van den Wyngaert I; Van der Linde H; Lu HR; Teuns G; Gallacher DJ Toxicol Appl Pharmacol; 2018 May; 346():45-57. PubMed ID: 29596924 [TBL] [Abstract][Full Text] [Related]
8. [Method for MEA Data Analysis of Drug-treated Rat Primary Neurons and Human iPSC-derived Neurons to Evaluate the Risk of Drug-induced Seizures]. Ojima A; Miyamoto N Yakugaku Zasshi; 2018; 138(6):823-828. PubMed ID: 29863054 [TBL] [Abstract][Full Text] [Related]
9. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. Winter MJ; Redfern WS; Hayfield AJ; Owen SF; Valentin JP; Hutchinson TH J Pharmacol Toxicol Methods; 2008; 57(3):176-87. PubMed ID: 18337127 [TBL] [Abstract][Full Text] [Related]
10. An integrated approach for early in vitro seizure prediction utilizing hiPSC neurons and human ion channel assays. Rockley K; Roberts R; Jennings H; Jones K; Davis M; Levesque P; Morton M Toxicol Sci; 2023 Oct; 196(1):126-140. PubMed ID: 37632788 [TBL] [Abstract][Full Text] [Related]
11. Can We Panelize Seizure? Roberts R; Authier S; Mellon RD; Morton M; Suzuki I; Tjalkens RB; Valentin JP; Pierson JB Toxicol Sci; 2021 Jan; 179(1):3-13. PubMed ID: 33165543 [TBL] [Abstract][Full Text] [Related]
12. A multi-laboratory evaluation of microelectrode array-based measurements of neural network activity for acute neurotoxicity testing. Vassallo A; Chiappalone M; De Camargos Lopes R; Scelfo B; Novellino A; Defranchi E; Palosaari T; Weisschu T; Ramirez T; Martinoia S; Johnstone AFM; Mack CM; Landsiedel R; Whelan M; Bal-Price A; Shafer TJ Neurotoxicology; 2017 May; 60():280-292. PubMed ID: 27036093 [TBL] [Abstract][Full Text] [Related]
13. Screening the ToxCast phase II libraries for alterations in network function using cortical neurons grown on multi-well microelectrode array (mwMEA) plates. Strickland JD; Martin MT; Richard AM; Houck KA; Shafer TJ Arch Toxicol; 2018 Jan; 92(1):487-500. PubMed ID: 28766123 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity, specificity and limitation of in vitro hippocampal slice and neuron-based assays for assessment of drug-induced seizure liability. Zhai J; Zhou YY; Lagrutta A Toxicol Appl Pharmacol; 2021 Nov; 430():115725. PubMed ID: 34536444 [TBL] [Abstract][Full Text] [Related]
15. Principal Component Analysis to Distinguish Seizure Liability of Drugs in Human iPS Cell-Derived Neurons. Ishibashi Y; Odawara A; Kinoshita K; Okamura A; Shirakawa T; Suzuki I Toxicol Sci; 2021 Nov; 184(2):265-275. PubMed ID: 34570236 [TBL] [Abstract][Full Text] [Related]
16. Measuring drug absorption improves interpretation of behavioral responses in a larval zebrafish locomotor assay for predicting seizure liability. Cassar S; Breidenbach L; Olson A; Huang X; Britton H; Woody C; Sancheti P; Stolarik D; Wicke K; Hempel K; LeRoy B J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):56-63. PubMed ID: 28712933 [TBL] [Abstract][Full Text] [Related]
17. Multi-well microelectrode array recordings detect neuroactivity of ToxCast compounds. Valdivia P; Martin M; LeFew WR; Ross J; Houck KA; Shafer TJ Neurotoxicology; 2014 Sep; 44():204-17. PubMed ID: 24997244 [TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity screening of new psychoactive substances (NPS): Effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA). Zwartsen A; Hondebrink L; Westerink RH Neurotoxicology; 2018 May; 66():87-97. PubMed ID: 29572046 [TBL] [Abstract][Full Text] [Related]
19. From the Cover: Developmental Neurotoxicants Disrupt Activity in Cortical Networks on Microelectrode Arrays: Results of Screening 86 Compounds During Neural Network Formation. Frank CL; Brown JP; Wallace K; Mundy WR; Shafer TJ Toxicol Sci; 2017 Nov; 160(1):121-135. PubMed ID: 28973552 [TBL] [Abstract][Full Text] [Related]
20. Development of a Drosophila seizure model for in vivo high-throughput drug screening. Stilwell GE; Saraswati S; Littleton JT; Chouinard SW Eur J Neurosci; 2006 Oct; 24(8):2211-22. PubMed ID: 17074045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]